Back to company

Pharma Native ApS: Financial statements 2024

CVR: 44114976

Pharma Native ApS (CVR 44114976) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,537,564 and a net result of DKK 77,485. Equity amounted to DKK 266,948. The solvency ratio was 60.2%. The company had 1 employee in the financial year.

Gross Profit
1,537,564 kr.
Profit/Loss
77,485 kr.
Equity
266,948 kr.
Total Assets
443,799 kr.
Employees
1

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Pharma Native ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2024

Pharma Native ApS publishes interim reportFeb 6, 2024

Pharma Native ApS has published its interim report for the period June 12, 2023 – December 31, 2023.

About Pharma Native ApS

Pharma Native ApS is a Danish company of the type Anpartsselskab based in Værløse, founded in 2023. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Jacob Ekstrøm. The company is owned by Jacob Ekstrøm. In 2025, the company reported a gross profit of DKK 989,531 and a net result of DKK 124,011 compared with DKK 77,485 the year before. Equity amounted to DKK 255,959.

Other financial years